A detailed history of Orbimed Advisors LLC transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 1,927,000 shares of KZR stock, worth $1.48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,927,000
Previous 1,927,000 -0.0%
Holding current value
$1.48 Million
Previous $1.73 Million 33.33%
% of portfolio
0.03%
Previous 0.04%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.72 - $1.15 $2.55 Million - $4.07 Million
-3,536,000 Reduced 64.73%
1,927,000 $1.83 Million
Q1 2023

May 15, 2023

BUY
$3.13 - $7.31 $2.75 Million - $6.42 Million
878,678 Added 19.17%
5,463,000 $17.1 Million
Q4 2022

Feb 14, 2023

BUY
$6.39 - $8.8 $18 Million - $24.8 Million
2,812,622 Added 158.75%
4,584,322 $32.3 Million
Q3 2022

Nov 14, 2022

BUY
$7.99 - $10.75 $2.81 Million - $3.78 Million
351,800 Added 24.78%
1,771,700 $15.3 Million
Q2 2022

Aug 15, 2022

BUY
$4.58 - $17.13 $6.5 Million - $24.3 Million
1,419,900 New
1,419,900 $11.7 Million
Q4 2021

Feb 14, 2022

SELL
$7.44 - $16.72 $8.56 Million - $19.2 Million
-1,150,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$4.85 - $9.73 $2.88 Million - $5.77 Million
592,809 Added 106.39%
1,150,000 $9.94 Million
Q2 2021

Aug 16, 2021

BUY
$4.93 - $6.46 $2.75 Million - $3.6 Million
557,191 New
557,191 $3.03 Million

Others Institutions Holding KZR

About Kezar Life Sciences, Inc.


  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $52.6M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.